| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JNEUROIM.2008.08.012 |
| P698 | PubMed publication ID | 18829119 |
| P2093 | author name string | Xin Xu | |
| John C McKew | |||
| James D Clark | |||
| Takao Shimizu | |||
| Paresh Thakker | |||
| Lixin Han | |||
| Katherine L Lee | |||
| Michael W Leach | |||
| Mina Hassan-Zahraee | |||
| Junqing Cui | |||
| Nancy L Stedman | |||
| Fran Donahue | |||
| Marina W H Shen | |||
| Jeffrey W Pelker | |||
| Suzana Marusic | |||
| Adam J Borey | |||
| Stan F Wolf | |||
| P433 | issue | 1-2 | |
| P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
| P304 | page(s) | 29-37 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | Journal of Neuroimmunology | Q15716691 |
| P1476 | title | Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses | |
| P478 | volume | 204 |
| Q35678040 | Aspirin and multiple sclerosis |
| Q35185104 | Breast-fed and bottle-fed infant rhesus macaques develop distinct gut microbiotas and immune systems |
| Q38728679 | Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases. |
| Q35886245 | Cytosolic phospholipase A₂: physiological function and role in disease |
| Q37112554 | G protein-coupled receptors as therapeutic targets for multiple sclerosis |
| Q37310621 | Immunomodulatory and anti-inflammatory effects of chondroitin sulphate |
| Q37713745 | Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis. |
| Q48292469 | In Utero Exposure to Histological Chorioamnionitis Primes the Exometabolomic Profiles of Preterm CD4+ T Lymphocytes |
| Q35028421 | Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage |
| Q36188186 | Integrating cytosolic phospholipase A₂ with oxidative/nitrosative signaling pathways in neurons: a novel therapeutic strategy for AD. |
| Q57188392 | Ketogenic diets attenuate cyclooxygenase and lipoxygenase gene expression in multiple sclerosis |
| Q48244593 | Leukotrienes induce the migration of Th17 cells |
| Q33886424 | Localization and function of cytosolic phospholipase A2alpha at the Golgi |
| Q37765687 | Phospholipase A2 and arachidonic acid in Alzheimer's disease |
| Q37658843 | Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases. |
| Q37710103 | Prostaglandins in pathogenesis and treatment of multiple sclerosis |
| Q37694624 | Protective effect of cytosolic phospholipase A2 inhibition against inflammation and degeneration by promoting regulatory T cells in rats with experimental autoimmune encephalomyelitis |
| Q26863534 | Role of prostaglandins in neuroinflammatory and neurodegenerative diseases |
| Q49438941 | Salate derivatives found in sunscreens block experimental autoimmune encephalomyelitis in mice |
| Q34329492 | Sphingolipids in multiple sclerosis |
| Q90341485 | Systematic Understanding of Bioactive Lipids in Neuro-Immune Interactions: Lessons from an Animal Model of Multiple Sclerosis |
| Q37463199 | Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis |
| Q38064420 | Targeting monocytes/macrophages in the treatment of rheumatoid arthritis. |
| Q35028003 | Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination. |
Search more.